| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 06/06/2002 | US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/06/2002 | US20020068283 Suppressor mutations for common P53 cancer mutations |
| 06/06/2002 | US20020068070 High molecular weight major outer membrane protein of moraxella |
| 06/06/2002 | US20020068069 spsA polynucleotides and polypeptides |
| 06/06/2002 | US20020068068 Pathogenic bacteria (e.g. Haemophilus, E. Coli, Salmonella) having non-reverting genetic mutations which alter activity of DNA adenine methylase (Dam); vaccines |
| 06/06/2002 | EP1144454A3 Modified peptides as therapeutic agents |
| 06/06/2002 | DE10060140A1 Multimerer mehrfach-antigenbindender einzelkettiger Antikörper Multimeric multiple antigen-binding single chain antibody |
| 06/06/2002 | DE10059105A1 New enzyme with amylolytic and cyclodextrin glucanotransferase activities, useful for textile cleaning and in pharmaceutical compositions |
| 06/06/2002 | DE10058379A1 Neuer Hefestamm für den Verzehr New yeast strain for consumption |
| 06/06/2002 | DE10058091A1 Isolierte Luziferasen Lu164, LuAL und Lu22, sowie deren Verwendung Isolated luciferases Lu164, LuAL and Lu22, and their use |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | CA2433665A1 Projection against mycobacterial infections |
| 06/06/2002 | CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | CA2430745A1 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | CA2430559A1 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430365A1 Neurotoxins with enhanced target specificity |
| 06/06/2002 | CA2430351A1 Human protooncogene and protein encoded therein |
| 06/06/2002 | CA2430331A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/06/2002 | CA2430292A1 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 06/06/2002 | CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | CA2430084A1 Obp1:a protein selectively expressed in osteoblasts |
| 06/06/2002 | CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | CA2430080A1 Eukaryotic expression libraries based on double lox recombination and methods of use |
| 06/06/2002 | CA2429814A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2429469A1 Human elongase genes and uses thereof |
| 06/06/2002 | CA2425872A1 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/05/2002 | EP1211316A1 Mutants of mycobacterium vaccae-derived formate dehydrogenase and uses thereof |
| 06/05/2002 | EP1211315A1 Recombinant vectors for producing HCV envelope proteins |
| 06/05/2002 | EP1211312A2 Method for sterilizing transformed cells |
| 06/05/2002 | EP1211310A1 Novel yeast variants and process for producing glycoprotein containing mammalian type sugar chain |
| 06/05/2002 | EP1210990A2 Method for the treatment of soils polluted by heavy metal compounds and related plant of treatment |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210449A1 Methods for the detection, analysis and isolation of nascent proteins |
| 06/05/2002 | EP1210445A2 Recombinant microorganisms |
| 06/05/2002 | EP1210443A1 High specificity homocysteinases |
| 06/05/2002 | EP1210442A1 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS |
| 06/05/2002 | EP1210441A2 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 06/05/2002 | EP1210440A1 Taq dna polymerases having an amino acid substitution at e681 and homologs thereof exhibiting improved salt tolerance |
| 06/05/2002 | EP1210438A2 Ehrlichia canis genes and vaccines |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210434A2 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 06/05/2002 | EP1210430A2 Muc-1 derived peptides |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |
| 06/05/2002 | EP1210426A2 Polymorphisms in a klotho gene |
| 06/05/2002 | EP1210424A1 Novel b7-4 molecules and uses therefor |
| 06/05/2002 | EP1210423A1 Novel abc transporter and uses thereof |
| 06/05/2002 | EP1210422A2 Human abc2 transporter and uses thereof |
| 06/05/2002 | EP1210421A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210413A1 Phytase enzymes, nucleic acids encoding phytase enzymes and vectors and host cells incorporating same |
| 06/05/2002 | EP1210412A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 06/05/2002 | EP1210410A2 Metal binding compounds and their use in cell culture medium compositions |
| 06/05/2002 | EP1210408A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 06/05/2002 | EP1210407A1 Bacterial consortium ebc1000 and a method using the bacterial consortium ebc1000 for remedying biologically recalcitrant toxic chemicals contained in industrial wastewater, waste materials and soils |
| 06/05/2002 | EP1210406A2 Flocculation of cell material |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210366A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 06/05/2002 | EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 06/05/2002 | EP1210111A1 Gamma-herpesvirus dna and methods of use |
| 06/05/2002 | EP1037658B1 Ifnar/ifn complex |
| 06/05/2002 | EP0960132B1 Polysaccharide, micro-organism and method for obtaining same, composition containing it and application |
| 06/05/2002 | EP0877805B1 Tandem fluorescent protein constructs |
| 06/05/2002 | CN1352691A Human complement C3-degrading polypeptide from i(streptococcus pneumoniae) |
| 06/05/2002 | CN1352688A Mutant 1,3-propanediol dehydrogenase |
| 06/05/2002 | CN1352687A A variant of c6 beta-chemokine leukotactin-1 (shLKn-1) with enhanced biological activity |
| 06/05/2002 | CN1352685A Monomcyte-derived nucleic acids and rolated compositions and methods |
| 06/05/2002 | CN1352684A Vascular endothelial cell growth factor variants and use thereof |
| 06/05/2002 | CN1352683A Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/05/2002 | CN1352241A Self flocculation saccharomycetes strain for alcohol fermentation |
| 06/05/2002 | CN1351818A Planting method for glossy ganoderma containing trace elements selenium and germanium and rare earths |
| 06/04/2002 | US6399762 Methods and compositions for diagnosing and treating chromosome -18p related disorders |
| 06/04/2002 | US6399755 A nucleic acid; diagnosis and therapy for human cancers |
| 06/04/2002 | US6399747 A polypeptide for screening transgenic animals and testing drugs for their ability to block cell proliferation |
| 06/04/2002 | US6399573 Interleukin-1 receptor antagonist beta (IL-1rabeta) |
| 06/04/2002 | US6399571 Polypeptides |
| 06/04/2002 | US6399382 Synthase catalyst biosynthesis |
| 06/04/2002 | US6399368 A genetically engineered cloning vector containing a inducible promoter, leader sequence and a soluble t-cell receptor variable domain; therapy for autoimmune diseases and cancer |
| 06/04/2002 | US6399350 Screening for modulators by exposing kuz polypeptide to protease substrate in presence of modulating agent which can be an antibody, dominant negative fragment of the polypeptide or enzyme inhibitor |
| 06/04/2002 | US6399348 DNA sequences for matrix metalloproteases, their production and use |
| 06/04/2002 | US6399347 Rhamnogalacturonan hydrolases |
| 06/04/2002 | US6399344 Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding receptors |
| 06/04/2002 | US6399342 Amino acid sequence of polypeptide isolated from anabaena or synechococcus; for transgenic plants with altered herbicide resistance |
| 06/04/2002 | US6399340 Vector derivatives of gluconobacter plasmid pF4 |
| 06/04/2002 | US6399338 High yield production by culturing rhizopus azygosporus in medium, then isolating chitosan or chitin from culture |
| 06/04/2002 | US6399337 Culturing host cell modified by polynucleotide encoding the enzyme of defined amino acid sequence, then host cell with substrate suitable to produce a fucosylated oligosaccharide |
| 06/04/2002 | US6399334 Calibration of nucleotide sequences; generate preferential nucleotide sequences, incubate with hapten, remove and evaluate hybridized nucleotide sequences |
| 06/04/2002 | US6399332 Dna which codes staphylococcal enterotoxin a of defined amino acid sequence which has been attenuated by amino acid mutation causing altered binding to major histocompatibility complex class ii and t cell antigen receptors |
| 06/04/2002 | US6399330 Nucleotide and amino acid sequences of crystal/insecticidal proteins; active against japanese beetle and red flour beetle; biological pest control |
| 06/04/2002 | US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents |
| 06/04/2002 | US6399321 Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT |
| 06/04/2002 | US6399320 Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction |
| 06/04/2002 | US6399312 Myostatin gene promoter and inhibition of activation thereof |
| 06/04/2002 | US6399296 Detecting specific protein in sample by contacting with second protein having reduced structural flexibility due to recombinantly introduced disulfide bonding, allowing proteins to complex, then detecting complex |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 06/04/2002 | US6399067 Methods and compositions for impairing multiplication of HIV-1 |